<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Tsai, F.Y.</title>
    <link>http://repub.eur.nl/res/aut/2825/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/8410/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>GATA-2 is an essential transcription factor in the hematopoietic system
      that is expressed in hematopoietic stem cells (HSCs) and progenitors.
      Complete deficiency of GATA-2 in the mouse leads to severe anemia and
      embryonic lethality. The role of GATA-2 and dosage effects of this
      transcription factor in HSC development within the embryo and adult are
      largely unexplored. Here we examined the effects of GATA-2 gene dosage on
      the generation and expansion of HSCs in several hematopoietic sites
      throughout mouse development. We show that a haploid dose of GATA-2
      severely reduces production and expansion of HSCs specifically in the
      aorta-gonad-mesonephros region (which autonomously generates the first
      HSCs), whereas quantitative reduction of HSCs is minimal or unchanged in
      yolk sac, fetal liver, and adult bone marrow. However, HSCs in all these
      ontogenically distinct anatomical sites are qualitatively defective in
      serial or competitive transplantation assays. Also, cytotoxic drug-induced
      regeneration studies show a clear GATA-2 dose-related proliferation defect
      in adult bone marrow. Thus, GATA-2 plays at least two functionally
      distinct roles during ontogeny of HSCs: the production and expansion of
      HSCs in the aorta-gonad-mesonephros and the proliferation of HSCs in the
      adult bone marrow.</description>
    </item> <item>
      <title>GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2541/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>We previously demonstrated that the zinc finger transcription factors GATA-2 and GATA-3 are expressed in trophoblast giant cells and that they regulate transcription from the mouse placental lactogen I gene promoter in a transfected trophoblast cell line. We present evidence here that both of these factors regulate transcription of the placental lactogen I gene, as well as the related proliferin gene, in trophoblast giant cells in vivo. Placentas lacking GATA-3 accumulate placental lactogen I and proliferin mRNAs to a level 50% below that reached in the wild-type placenta. Mutation of the GATA-2 gene had a similar effect on placental lactogen I expression, but led to a markedly greater reduction (5- to 6-fold) in proliferin gene expression. Placentas lacking GATA-2 secrete significantly less angiogenic activity than wild-type placentas as measured in an endothelial cell migration assay, consistent with a reduction in expression of the angiogenic hormone proliferin. Furthermore, within the same uterus the decidual tissue adjacent to mutant placentas displays markedly reduced neovascularization compared to the decidual tissue next to wild-type placentas. These results indicate that GATA-2 and GATA-3 are important in vivo regulators of trophoblast-specific gene expression and placental function, and reveal a difference in the effect of these two factors in regulating the synthesis of related placental hormones.</description>
    </item>
  </channel>
</rss>